GL Rapha Plans to Launch “Sputnik V” Vaccine Production in January 2021

GL Rapha, one of the leading South Korean bio-tech companies, plans to launch full-scale production of Russia’s coronavirus vaccine Sputnik V in January 2021, Maeil Gyeongje newspaper reported.

According to the newspaper, the company has already launched production of a pilot batch, which it will send to Russia this month for checks. In case no violations are found, industrial production of Sputnik V in the republic will kick off in January.

All vaccine doses produced in South Korea will be exported to the Middle East.

On November 13, the Russian Direct Investment Fund and South Korea’s GL Rapha reached an agreement to produce more than 150 mln doses of the Sputnik V coronavirus vaccine in South Korea per year. The sides “intend to commence production in December 2020 and a rollout of the Sputnik V vaccine in January 2021,” a press release said.

Source